GSK acquires minority stake in Convergence Pharma
Convergence Pharmaceuticals has recently raised $35.4m in Series A financing from a syndicate of European and US life science investors. Under the terms of the agreement, Convergence Pharmaceuticals
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.